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The demonstration of the causative role of an organism in leprosy presents  diffi- 
culties not present in other diseases.  An acid-fast bacterium, not cultivable by present 
techniques,  is found in the patients'  lesions;  it is  designated Mycobacterium leprae. 
The histopathology of the disease  and its  drug sensitivity are compatible with  the 
notion that the disease  is caused by a mycobacterium. By the inoculation of mouse 
foot-pads a non-cultivable mycobacterium can be isolated with regularity from clini- 
cal specimens containing M. leprae and apparently not from other specimens (1, 2). 
A relationship between the dose of M./eprae inoculated and the incubation period of 
the experimental  disease  further  relates  the isolate  to M.  leprae. The experimental 
disease  in mice is similar to the natural disease  in that it is very slow in development 
and there is a  large, round cell response without necrosis,  but it is dissimilar in that 
the nerves are not often involved.  Antibody studies have not been helpful because 
of the widespread cross-reactions among mycobacterial species. 
Fortunately the lepromin  reaction  in leprosy patients  has  a  unique  specific  im- 
munological aspect that may be applied to test an isolate from the disease; this was 
pointed out by I-Iayashi 30 years ago (3).  Lepromin is prepared from lepromas and 
contains large numbers of M.  leprae. The tissue is boiled or autoclaved, ground in 
a  mortar with  saline,  and  faltered  through gauze  (4).  After injection into  the  skin 
there may be an early (Fernandez) reaction with a maximum at about 48 hours, and 
a  late  (Mitsuda)  reaction with a  maximum at  14 to 28 days. The specific  aspect of 
the test ties in the lack of reaction by patients with the lepromatous form of the disease, 
a  more severe  type in which bacilli  in the  tissues  are numerous.  In contrast, most 
patients  do react who have  the  tuberculoid  disease,  a  different and milder  clinical 
form in which bacilli are few. The test of a purported isolate of M./eprae can be made 
stringent by several measures,  all of which were followed in this study.  (a)  A large 
group of patients, preferably adults, should be tested, since some persons, especially 
children, fail to react to leprosy and other mycobaeterial antigens  (5). If children are 
induded in the study, a  correlation between two antigens could arise from age differen- 
ces of the subjects rather than from immunological relationships between the mycobae- 
teria.  (b)  The late (Mitsuda) reading should receive primary attention, since the early 
reactivity of some antigens may be unpredictably low.  (c)  Whole bacillary antigens 
should  be  employed.  Antigens  purified  by extractions  with  organic  solvents  (e.g., 
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Dharmendra  antigens)  have  much  less  late  reactivity  (6).  Also extracts  of  certain 
non-leprosy organisms have been prepared that give more early reactions in tubercu- 
loid than in lepromatous patients (7). When points (b) and (c) are followed the results 
may  be  viewed in  terms  of  the experience reported  in  the literature,  obtained  pri- 
marily with late readings and unextracted  antigens.  Finally (d)  carry over of bacilli 
from  the  original  inoculum  into  the  test  antigen,  which  is  a  real  possibility  with 
clinical material from this disease, should be ruled out by quantitative data covering 
the history of the isolate. 
To  test  the  foot-pad  isolates  a  suspension  of bacilli  was  prepared  from in- 
fected foot-pads in the Atlanta laboratory  and it was tested at Cebu in leprom- 
atous  and  tuberculoid  patients.  Parallel  injections  of  a  standard  lepromin 
were given.  The  reactions  to  the  foot-pad  preparation  and  the  lepromin  cor- 
related to a  high degree. 
Materials and Methods 
The suspension of acid-fast bacilli from infected foot-pads was prepared from a  strain in 
fourth passage.  It was a  typical isolate and had originated in September,  1959, from nasal 
washings of a lepromatous patient from Puerto Rico. The bacillary increase was 5.6 X  102-, 
2.0 X  104-, 2.2 X  102-, and 1.1 X  103-fold in the respective 4 passages,  or a total of 2.7  X  10  t~- 
fold for all 4 passages. The chance that even 1 bacillus of the original inocuhim would have 
carried over into the skin test dose (1.6 X  106 bacilli) would be extremely small. 
The method used for preparation of the suspension was similar to that used for routine har- 
vests  of  infected  foot-pads  (1,  2).  The  mice  had  been  inoculated  about  7  months 
earlier with 5.0  X  108 organisms. The lightly minced foot-pads of 8 mice were placed in the 
cup of a  Mickle tissue disintegator with about 20 3 mm glass beads  0dmax solid  glass,  No. 
13500, Kimble Glass Company, Toledo), 4 ml Hanks' balanced salt solution  containing 0.05 
per cent tween 80 (BSS-tween) added, and vibration carried out for 2 minutes with a measured 
amplitude of 5 ram. The resulting suspension was then removed to a test tube. The aggregation 
of skin fibers was accelerated by mixing with bulb and pipette, the aggregates and visible pieces 
of tissue allowed to settle for 2 minutes, and the supematant carefully pipetted off (this process 
called "taking a  2 minute supernatant").  If necessary, a further 2 minute supernatant  was 
taken. The Mickle cup and 2 minute sediments were washed with a  single 2  ml portion of 
BSS-tween, and the resultant supernatant was added to the previous supernatant.  An equal 
volume was then added of 0.25 per cent trypsin (Nutritional Biochemicals Corp., Cleveland, 
1:300,  in saline buffered to pH 7.6 and containing 0.001  per cent phenol red). The pH  of 
the mixture was adjusted  to pH  7.6 with N/IO0 NaOH,  the suspension  stirred with  bulb 
and pipette, placed in a  37°C water bath for 5 minutes with occasional agitation  by hand, 
and  the suspension  again stirred with bulb  and  pipette.  If aggregates of fibers  appeared, 
a  2 minute supernatant  was taken. The suspension  was then chilled in ice water  and cen- 
trifuged  at  4°(2 at  3000  ge,x  for  30  minutes.  The  supernatant  was  discarded,  and 
the sediment was resuspended  to volume in chilled 0.85 per cent saline buffered  to pH 7.3 
and  containing 0.05  per cent tween 80  (pH  7.3 saline-tween), and  the cold  centrifugation 
repeated.  The  supernatant  was  discarded,  the  sediment  resnspended  to  1  ml  in  pH  7.3 
saline-tween, and thimerosal added to 1:10,000.  Each preparation was completed in 1 day, and 
the final 1 ml stored at 4°C. The yields at several stages during each work-up were determined 
by counts of acid-fast bacilli. The operation was repeated 16 times (total 128 mice), the final 
1 ml portions pooled, a 2 minute supernatant taken, and autoclaving carried out at 15 pounds CHARLES  C.  SHEPARD  AND  R.  S.  GUI'NTO  197 
for 15 minutes. The total yield for all 16 operations was 70.6 X  l0  T acid-fast bacteria (AFB) 
before  trypsinization,  70.6  X  l0  T after  trypsin~tion,  45.3  X  107  before  autoclaving, 
and 22.3 X  10  ~ after autoclaving. The final product had a content of 1.57 X  10  ~ AFB/ml. The 
standard lepromin (Mabalay) contained 4.18 X  l0  T AFB/mi, so a portion of it was diluted 
1:2.66 to contain 1.57  X  10  ~ AFB/ml. Thus there were 3 products: A, the preparation from 
foot-pads containing 1.57 X  107 AFB/ml; B, the diluted standard lepromin containing 1.57 X 
TABLE I 
Sex and Age Distribution of Patients Te~t~ with Antigens A, B, and C 
Lepromatous  Tuberculold 
Age group 
Male  Female  Total  Male  Female  Total 
~rs, 
10-14 
15-19 
20-29 
30-39 
40-49 
50 over 
Total ..... 
3 
9 
11 
23 
m 
2 
5 
4 
11 
3 
11 
16 
4 
34  20 
4 
3 
1 
2 
10  30 
TABLE  H 
Clinical Status of Palien~s Tested ~ith Antigens A, B, and C 
Clinicalstat~ 
L-1 
L-2 
L-3 
Lepromatous 
No. 
7 
10 
17 
Per cent 
20.6 
29.4 
50.0 
Clinical status 
T-1 
T-2 
T-3 
Tubercaloid 
NO. 
7 
12 
ii 
Per cent 
23.3 
40.0 
36.6 
Total..  34  1130.0  30  99.9 
The clinical status is given as  1  (slight), 2  (moderately advanced),  and 3  (advanced). 
107 AFB/ml; and C, the undiluted standard lepromin containing 4.18 X  10 z AFB/ml. They 
were marked A, B, and C, and sent to Cebu without further designation. 
The 34 adults with active lepromatous leprosy and 30  patients  (28  adults  and  2 chil- 
dren over 10 years)  with clear-cut tuberculoid lesions were tested simultaneously with the 
3 antigens. The two groups were roughly matched for age and sex (Table I), and all were pa- 
tients at the Eversley Chllds Sanitorium, Cebu. The clinical and bacteriological conditions are 
given in Tables II and HI. The tuberculoid patients were, or had been, bacteriologically posi- 
tive, reactional tuberculoid cases, since positive bacteriology was a  condition for admission. 
Thus they probably tended to be less reactive to lepromin than would have a comparable group 
of non-reactional tuberculoid cases. The sites of injection were (a) left upper forearm, (b) left 
lower forearm, and (c) right middle forearm. The dose of 0.1 ml of antigens A, B, or C were in- 198  IDENTIFICATION OF  MYCOBACTERIU~  LEPRAE 
jected intradermally into sites a, b, or ¢ at random,  as determined previously from a  llst of 
random numbers. The reactions were read at 24, 48, and 72 hours for early  (Fernandez) reac- 
tions of the tuberculin type and at 14, 21, and 28 days for late (Mitsuda)  nodular reactions. 
The recorded measurements were the average of the horizontal and vertical diameters of in- 
duration in millimeters. 
Although it had been intended that the antigens be treated as unknowns, this was not possi- 
ble because their gross appearance identified them, antigen A  being nearly water clear and 
antigens B and C definitely turbid. Accordingly the injections were made by Dr. T. Fajardo, 
Jr., and the reactions were measured by Dr. Guinto without knowledge of the antigen assigned 
to the site. 
TABLE III 
Bacteridog@al Status of Patients Tested with Antigens A, B, and C 
Average bacteriological 
score* 
0 
V.S. or+ 
++ 
+++ 
++++ 
Total ........... 
No. 
m 
5 
12 
17 
34 
Lepromatous 
Per cent 
14.7 
35.3 
50.0 
100.0 
No. 
10 
16 
3 
1 
30 
Tubercu[oid 
Per cent 
33.3 
53.3 
10.0 
3.3 
99.9 
* Average from smears at all sites tested; V.S. stands for very sparse;  +  to -J-+++  for 
increasing numbers of acid-fast bacteria. 
The suspensions  of the N isolate of Binford (8, 9) had been prepared and tested at an earlier 
date. The N preparation was simply the growth in tween-albumin medium, washed thoroughly 
by centrifugation and  resuspension  in pH 7.3 saline-tween. The NT preparation  originated 
from infected hamster testes supplied by Dr. Binford. It was purified by a density gradient 
procedure that was similar to one described for Q fever rickettsiae (10).  The gradients were 
continuous and linear from 3 to 40 per cent sucrose in 1 ~ KC1 with 0.05 per cent tween 80, and 
30 minutes at 3000 ~  were required to move the bacillary band to the middle third of the 
gradient. This band was of a high degree of purity, and it was concentrated by one centrifuga- 
tion and resuspension in pH 7.3 saline-tween and dialyzed against the same. The final yield 
3.38  X  109 AFB from 15.1 gm testes. Both the N and NT antigens were diluted to 5.0 X  107 
AFB/ml and autoclaved at 15 pounds for 15 minutes. This concentration had been selected 
on the basis of comparison to another standard lepromin (Wade), the bacillary content of which 
was a little greater than the Mabalay lepromin. Application of the density gradient procedure 
to foot-pad preparations was unsuccessful because of serious losses in acid-fast bacteria. 
RESULTS 
None  of the J  antigens gave positive reactions,  early or late,  in any  of the 
34 lepromatous patients  (Table IV). In marked contrast,  among the 30 patients 
with  tuberculoid  leprosy  definitely positive  late  (Mitsuda)  nodular  reactions 
larger than 4  mm were observed in 20 (66.7 per cent)  with antigen A, 21  (70.0 CHARLES  C.  SHEPA1LD AI~'D R.  S.  GU'r.2qTO  199 
per cent) with antigen B, and in 27 (90.0 per cent) with antigen C. Thus the 
foot-pad antigen (A) produced Mitsuda reactions that were closely comparable 
to the standard  lepromin of similar bacillary content  (B). 
The close correlation between antigens A and B is shown in Fig. 1, where the 
readings in the individual tuberculoid patients at 21 days are plotted. A was 
perhaps a little weaker than B, and both were weaker than C. 
There were differences  between A and B in the number of early reactions; 
probably this is a reflection  of the fact that soluble antigens would have been 
removed in the preparation of A. There were also slight differences in the rate 
TABLE  IV 
Frequency and Size of Early and Late Reactions to Antigens A, B, and C 
Optimum early reaction  Optimunl late reaction 
(24, 48, or 72 hrs.)  (14, 21, or 28 days) 
.  . --~e  e 
Doubt-  ~  ~  ~  d  [ Doubt- I  ]  ~ I  ~ ] 
~'  +~  ~ 
31  2  34 
34  34 
24  10  --  --  --  34 
19  7  2  2  --  13.3  2  8  15]  3]  2  66.7 
/  I 
16  5  81  1--30.0  3  6  15  3  3  70.0 
I 
9111  5 I  3[  233.3  1  I  21181  41  "5190"0 
Antigen 
1.  Lepromatous, 34 
patients 
A ............ 
B  ............ 
C  ............ 
2.  Tuberculoid, 30 
patients 
A  ............ 
B  ............ 
C  ............ 
at which the means of the late reactions changed with time, antigen A reaching 
a peak at 21 days and antigen B at 28 days. Similar  differences  were seen be- 
tween different preparations of lepromin. 
Reactions to N  and NT Suspensions.--The  suspensions  prepared  from the 
N isolate were tested in leprosy patients also. All had been tested with Mabalay 
lepromin within the previous 3 months. The late (Mitsuda) reactions were as 
follows:  Of 66 lepromatous patients all had been negative to lepromin; 35 of 
these  were  tested  with  N  antigen  and  32  (91.4  per  cent)  were  positive; 
the remaining  31  were tested with NT antigen  and  31  (100 per cent)  were 
positive.  Of 20  tuberculoid patients  19  (95  per  cent)  had  been positive to 
lepromin;  10 of these were tested with N  antigen and 10 (100 per cent) were 
positive to N  antigen; the remaining  10 were tested with NT antigen and  10 200  IDENTIFICATION  0]~  MYCOBACTERIU~  LEPRAE 
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(100 per cent) were positive. Thus there were no important differences  in the 
reactivity of lepromatous and tuberculoid patients  to suspensions of the N 
isolate. The early  (Fernandez)  reactions  to the N  antigens  were also about 
the same in the two types of patients. 
TABLE V 
Late (Mitsud¢)  Skin Reactions to Various Bacillary Antigens in Leprosy Patients 
13-18. 
1. Lepromin (contains M. leprae) : Negative in lepromatous, positive in most tuberculoid 
patients. 
2.  Foot-pad isolates: Same as lepromin, (this paper). 
3.  N  isolate in hamster testes: Positive in 91 to 100 per cent of lepromatous and tu- 
berculoid patients (this paper). 
4. M. tuberculosis: Positive in estimated* 88 per cent of lepromatotm patients (Guinto, 11  ). 
5.  M. avium:  Positive in estimated* 83 per cent of lepromatous patients (Guinto, 11). 
6.  M. leprae-murium:  No correlation with lepromin (Hayashi, 3; Muir, 12; Sato and 
Sato, 13; Ohtawara and Kamamura, 14). 
7.  M. ph/e/: No correlation with lepromin (Hayashi, 3). 
8-12.  Purported isolates of M. leprae by Clegg, Needham, McCoy, Duval, and Kedrowsky: 
No correlation with lepromin (Hayashi, 3). 
BCG, M. fortuitum, M. rhodocrous, M. marinum,  M. phlei, M. smegmatis: No cor- 
relation with lepromin in 48 leprosy patients (16 lepromatous, 30 tuberculoid, and 
2 atypical) (McFadz~an, 15). 
* Estimated on the assumption that patients that reacted to tuberculins for these or- 
ganisms would have had positive Mitsuda reactions. In reality only those who were tuberculin- 
negative were tested with bacillary antigens and 65 and 46 per cent, respectively, responded 
with Mitsuda reactions. 
DISCUSSION 
The specificity of the lepromin reaction is given by the results in Table V in 
which are gathered results from this paper and other sources. The reactions of 
none of the 16 other mycobacterial cultures correlated with those of lepromln. 
Thus the failure of the lepromatous patient  to react to lepromin is specific, 
and it is not part of a general lack of reactivity such as the general failure to 
manifest  tuberculln-type  hypersensitivity  to  all  antigens  by patients  with 
sarcoidosis,  Hodgkin's disease,  and advanced malignant  states  (16).  McFad- 
zean's results  (15)  also attest to the specificity of the Mitsuda reactions  to 
other mycobacteria, since he failed to find correlation between antigens of other 
mycobacteria,  except  between  BCG  and  Mycobaaerium marinum, species 
already known to be antigenically related. 
The relationship of the lepromin reactions to more widely known immuno- 
logic skin tests is indicated by the timing. The early (Fernandez) reaction seems 
to be a  tuberculin-type reaction in every respect.  ("Tuberculin-type" is here 
used synonomously with "delayed-type" of the general immunologic literature 202  IDENTIFICATION  OF  MYCOBACTERIUM  LEPRAE 
in order to avoid confusion with the late, Mitsuda, reaction to lepromin.) The 
late (Mitsuda) reaction suggests the graft rejection phenomenon in its slowness; 
there is enough time for a new immunologic response to form against the intro- 
duced antigen itself. The lateness of the Mitsuda reaction may also be a func- 
tion of the time at which protoplasmic antigen is released from intact bacilli; 
M. leprae (17)  in common with other slowly growing mycobacteria (18)  has 
an antigen-free outer surface, in that it is not stainable with fluorescent anti- 
body until it is broken open. The classical criterion of tuberculin-type sensi- 
tivity, its transferability with white cells,  has not been tried with lepromin 
reactivity. 
The lepromin reaction has been viewed in leprology as an indicator of re- 
sistance to the disease (6). The lepromin negativity of the lepromatous patient 
can also be looked on as a form of immunologic tolerance (19),  since it repre- 
sents a specific inability to respond immunologically to antigen present in the 
tissues in large amounts (20). There is, of course, no conflict in these two views. 
This is perhaps best brought out by an analogy in generalized vaccinia. Kempe 
(21) reports that in vaccinia necrosum, a progressive form that is always fatal 
when untreated, there is usually complete lack of antibody formation to vac- 
cinia virus, even though there can be normal antibody response to other anti- 
gens. There is also lack of tuberculin-type sensitivity to heat-killed vaccinia 
virus. He describes a  case that continued to progress in spite of massive ad- 
ministration of antibody. Recovery occurred, however, when immune white 
cells  were  administered. 
SUMMARY 
Lepromin, a product containing Mycob~terium lepra~ from patients' tissues, 
fails to elicit skin reactions in lepromatous patients; this non-reactivity was 
utilized as a  means of identifying the mycobacterium isolated in mouse foot- 
pads from leprosy patients. To do this a suspension of acid-fast bacilli prepared 
from mouse foot-pads infected with a typical isolate was compared to human 
leprornin. The isolate was in fourth passage, and the multiplication since first 
isolation had diluted the original inoculum to insignificant levels. Three prepa- 
rations were tested: A, A  foot-pad preparation  containing  1.6  X  107  orga- 
nlsms/ml, B, lepromin diluted to the same bacillary content, and C, undiluted 
lepromin containing 4.2  X  107 organisms/ml. 
The reactions were compared in 34 lepromatous and 30 tuberculoid patients. 
All 34 lepromatous patients were negative in both early (Fernandez) and late 
(Mitsuda) reactions to all 3 antigens. In the tuberculoid patients the late reac- 
tions were positive in 66.7,  70.0 and 90.0 per cent to antigens A, B, and C, 
respectively. The size of the reactions to A and B were closely correlated in the 
individual patients. 
Experience  in  leprosy patients  with  suspensions  prepared  from  16  other CHARLES C.  SHEPARD AND R.  S.  GD-INTO  203 
mycobacterial cultures is reported or reviewed. None of them produced reac- 
tions  that  correlated with those of lepromin. Thus the lack of reactivity to 
lepromin of lepromatous patients appears to be a specific phenomenon. 
The results provide evidence that  the foot-pad isolates and M. lepraz  are 
immunologically identical. 
The careful work of Miss Mary Ann Downs and Mrs. Dorothy McRae, of the Communi- 
cable Disease Center, in the development and use of the preparation procedure is gratefully 
acknowledged. 
BIBLIOGRAPHY 
1.  Shepard, C.  C.,  The experimental  disease  that follows the injection of human 
leprosy bacilli  into foot-pads of mice,  J.  Exp.  Med.,  1960, 112,  445. 
2.  Shepard, C.  C.,  Multiplication  of Mycobaaerium le#raz in the foot-pad of the 
mouse, Intemat. J. Leprosy, 1962, 30, in press. 
3. Hayashi, F., Mitsuda's skin reaction in leprosy, Internat. J. Leprosy, 1933, 1, 31. 
4.  Expert Committee on Leprosy, 1st report, Worm Health Org. Tevhn. Rep. Series, 
1953, No. 71. 
5.  Guinto, R. S., and Wade, H. W., Results of tests with serial dilutions of lepromin 
in separate groups  of normal young children,  Internat. J. Leprosy, 1958, 9.6, 
328. 
6.  Expert Committee on Leprosy, 2nd report, World Health Org., Techn. Rep. Ser., 
1960, No. 189. 
7.  Chatterjee, K. R., Mukherjee, N., Sen, N. R., and Bose, R., Further observa- 
tions on the immunological skin test in leprosy with the antigen prepared from 
Kedrowsky's bacillus, Bull.  CalcuUa School Trop. Med.,  1956, 4, 163. 
8.  Binford,  C.  H.,  Histiocytic granulomatous  mycobacterial lesions  produced in 
the golden  hamster  (Cricetus auratus) inoculated  with human  leprosy,  Lab. 
Inv., 1959, 8, 901. 
9.  Shepard, C. C., Discussion, Tr. Syrup. Research  Le#rosy, Leonard Wood Memorial, 
1961, 245. 
10. Ribi, E., and ttoyer, B. It., Purification of Q fever rickettsiae by density gradient 
centrifugation, J. Immund., 1960, 85, 314. 
11.  Guinto, R. S, unpublished  results. 
12.  Muir,  E., The leprolin  test, LeWosy India,  1933, 5, 204; reprinted in Leprosy 
Rev., 1934, 6, 83. 
13.  Sato,  M.,  and  Sato,  ¥.,  Intrakutanreaktion  nach  Mitsuda  auf  lepr~isen and 
leprSsen  Patten, Japan.  J. Derm. and  Urol., 1935, 38, 67  (abstract section; 
original in Japanese). 
14.  Ohtawara,  T.,  and  Kamamura,  M.,  Studium  der  Lepra.  II.  Mitteilung.  Wie 
reagiert der Leprakranke auf die intrakutane Injection von Rattenleprabazil- 
len, Zentr. Bakt., 1. Abt., Orig., 1935, 134, 312. 
15.  McFadzean, J.  A.,  The  skin  reactions of patients with  leprosy to  the  intra- 
dermal inoculation  of mycobacterial antigens,  Tr. Royal Soc. Trop. Med. and 
Hyg., 1962, 56, 407. 204  IDENTIFICATION OF ~'YCOBACTERI~  LEPP.AE 
16.  Good, R. A., Kelly, W. D., Rotstein, J., and Varco, R. L., Immunological  de- 
ficiency diseases, Progr. Allergy,  1962, 6, 187. 
17.  Shepard,  C. C., unpublished results. 
18. Shepard,  C. C., and Kirsh, D., Fluorescent antibody stainability and other con- 
sequences  of the disruption of mycobacteria, Proc. Soc. Exp. Biol.  and Med., 
1961, 106, 685. 
19.  Chase,  M.  W.,  Immunologic  tolerance,  Ann.  Rev. Migrobiol.,  1959, 13,  349. 
20.  Shepard,  C. C., Discussion, Tr. Syrap. Researck Leprosy, Leonard Wood Memorial, 
1961, p. 250. 
21.  Kempe, C. H., Studies  on smallpox and complications  of smallpox  vaccination, 
Pediatr~;s, 1960, $6, 176. 